Efficacy and safety of poziotinib in treatment-naive NSCLC harboring HER2 exon 20 mutations: A multinational phase II study (ZENITH20-4)
Meeting Abstract
Cornelissen, R.; Sun, S.; Wollner, M.; Garassino, M. C. C.; Prelaj, A.; Haura, E. B.; Piotrowska, Z.; Goldman, J. W.; Socinski, M.; Dreling, L.; Bhat, G.; Lebel, F.; Le, X.